
ã«ããè»å µå£«ãCOVIDãžã£ã矩ååããããã«ããæ¿åºã«ããèšŽèšæ£åŽã®è©Šã¿ã«ãåãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
Valour Lawã®ãã£ãµãªã³ã»ã¯ãªã¹ãã³ã»ã³æ°ã¯LifeSiteNewsã«å¯Ÿããç®æèšŒèšãåçãåœé²åè¬ç·é·ã®ãŠã§ã€ã³ã»ãšã¢ãŒå°è»ãžã®ã¡ã¢ãªã©ãåœåŽã®äž»åŒµã«åè«ãã20äžããŒãžä»¥äžã®èšŒæ ãæã£ãŠãããšèªã£ãã
ã¢ã«ããŒã¿å·ã»ã³ãã»ã¢ã«ããŒãïŒLifeSiteNewsïŒ - ãéæ³ãªãCOVIDãžã£ãåœä»€ã®æŒãä»ãããããè»æå°è
ã«å¯Ÿãã5åãã«ã®éå£èšŽèšã§ãæ°çŸäººã®ã«ããè»ïŒCAFïŒçŸéå¡ããã³å
éå¡ã®ä»£ç人ãåããåŒè·å£«ã¯ãåœåŽãè£å€æã«èšŽããåŽäžããããæ±ããããšãåããè£å€æã圌ãã«æå©ãªç¥åŒå€æ±ºãäžãããæ±ããŠããã
6æãCAFã«å€åããŠãã300人以äžããã«ããåœé²åè¬ç·é·ïŒCDSïŒã®ãŠã§ã€ã³ã»ãšã¢ãŒå€§å°ãã2021幎10æ25æ¥ã確ç«ãããæ³åŸã𿲿³äžã®æš©å©ã«éåããéæ³ãªåœä»€ãäžããããšäž»åŒµããè»äººã«å®éšçãªCOVID-19ã®æ³šå°ãåããªããã°é€éããããæ±ãããšããŠãã«ããã®é£éŠè£å€æã«æèšŽããã
仿åããã¯ã©ãŠã³åŽã¯è£å€æã«çåŒæžãæåºãããã®èšŽèšã¯ ãåååŽã«äžå©ãªè²»çšãè² æ
ã㊠åŽäžãããã¹ãã§ãããšäž»åŒµãããã®èšŽèšã ã¹ãã£ã³ãã©ã¹ã§è»œèãç
©ç£ãªãã® ããšè¡šçŸããã
ãã®èšŽèšã¯ãååäžäººåœããããã100äžãã«ã®ééçæå®³è³ åãšãããã«100äžãã«ãã¯ããã«è¶
ãããã®ä»ã®æå®³è³ åãæ±ããŠãããåèšã§ããã5åãã«ã«ãªãã
åååŽã®ä»£ç人ã§ããValour Lawã®ãã£ãµãªã³ã»ã¯ãªã¹ãã³ã»ã³åŒè·å£«ã¯ãã©ã€ããµã€ããã¥ãŒã¹ã«å¯Ÿãã蚎èšãåŽäžããããšããåœåŽã®åãã¯äºæ³ãããããšã ãšè¿°ã¹ãã
ã¯ãªã¹ãã³ã»ã³ã¯ãã説æããããã ããç§ã¯ãçåŒæžã®æåŸã«ãããªãã¯åŒè·ããªãã£ãããç¥åŒè£å€ã«ããããšèšãè¿ãã®ã§ãããšã¯ãªã¹ãã³ã»ã³ã¯èª¬æããã
åœåŽã¯ãã«ããæš©å©èªç±æ²ç« éåãåŠå®ãããã¯ã¯ãã³æ¥çš®ã¯å®å
šã§å¹æçã§ããããã³ãããã¯ãžã®é©åãªå¯Ÿå¿ã®äžéšãšããŠåãå
¥ãããã ããšäž»åŒµããŠããã
ã¯ãªã¹ãã³ã»ã³ã¯LifeSiteNewsã«å¯Ÿããç®æè
ã®èšŒèšãåçãåœé²åè¬ç·é·ïŒCDSïŒã®ãŠã§ã€ã³ã»ãšã¢ãŒå°è»ã«å®ãŠãã¡ã¢ãªã©ããããã®äž»åŒµã«åè«ãã20äžããŒãžä»¥äžã®èšŒæ ããããšèªã£ãã
ãå€ã«ç«ããããå
µå£«ã®åçããããŸããã
ã圌ãå¯ãã®äžã§ç«ã£ãŠããåçã§ããæèã«ãããªããšãããããæŠäºç¯çœªã«ãªããŸãã
åŒè·åŽã¯å£°æã®äžã§ãååã«ã¯å®æçãªçç±ã§ã¯ã¯ãã³ã«å察ããæ©äŒãäžãããããšè¿°ã¹ãŠãããããããã¯ãªã¹ãã³ã»ã³ã¯ããã®éžæã«ã¯çµæã䌎ããšèšãã
ãã¯ã¯ãã³æ¥çš®ãä»äºãšçµã³ã€ããã®ã ãããããã¯åŒ·å¶ã ããšåœŒå¥³ã¯èšãã
ååã®åè«ã¯ãCAFã«ã¯ã¯ãã³æ¥çš®ãåœããCDSã®èœåãèªããŠãããããããåœé²æ³126æ¡ã«ãããæåŠããããšãå¯èœã§ããããã®å Žåã¯è»æ³äŒè°ã§è§£æ±ºããããšææããŠããã
åœåŽã®çåŒæžã§ã¯ãæ¿åºã¯ãå人æ
å ±ä¿è·æ³ã®äŸµå®³ã®çãããçãã蚎å ã¯ãªãããã®ãããªè«æ±ã¯æ£åŽãããã¹ãã§ãããšäž»åŒµããŠãããããã«å¯ŸããŠåååŽã¯æ¬¡ã®ããã«åè«ããïŒ
ãCAFã®ãããã¬ãã«ã¯ãCAFã®ã¡ã³ããŒå
šå¡ã®å»çæ©å¯æ
å ±ãå
¬éãããŠã§ããµã€ããäœæããããšã§ããã©ã€ãã·ãŒäŸµå®³ãããã«æªåããããã¢ã¯ã»ã¹ãå¶éãããã誰ããã®æ
å ±ãèŠãããšãã§ãããã管çããæªçœ®ã¯ãšãããŠããªãã£ããã
ã¯ãªã¹ãã³ã»ã³ã¯ãCFBãšãã¢ã³ãã³ã®ããã1000ã®ã«ã«ããããã¡ã€ã«ãèŠãé©åãªæš©éãæããªãCAFã®ã¡ã³ããŒã«ãã£ãŠã¢ã¯ã»ã¹ããããšè¿°ã¹ãã
ã誰ãã粟ç¥è¡çäžã®åé¡ãæ±ããŠããããæ§ææçã«ããã£ãŠããããäœãåé¡ãæ±ããŠããå Žåããããã®äººã
ã¯ãã®ãã¹ãŠã®æ
å ±ã«ã¢ã¯ã»ã¹ã§ããã®ã§ãã
ãã®è£å€ã¯ãæ°çŸäººã®ååã®èšŒèšãåœåŽãæ€èšŒããããšã«ãªããããä»åŸäœå¹Žã決çãã€ããªããšèŠãããŠããããããã®èšŒèšã«ããã°ãCAFã®ã¡ã³ããŒãã¡ã¯ãCOVID-19ã¯ã¯ãã³ãæ¥çš®ããªããšããæ±ºå®ãããããšã§å·®å¥ãåãããšãããCAFã®ã¡ã³ããŒã®å€ãã¯ãå±èŸ±ãšæé€ãããçµæã«èããããããCAFãå»ãããšã匷èŠãããªããéžæãããåŠçœ°ã«ã¯ã転å±
ãå
¬ã®å Žã§ã®ã¬ããã«è²Œããå«ãŸããããããã€ãããã¯ã仲éã®è¬åã«åºåžããããšããæåŠãããã
ã¯ãªã¹ãã³ã»ã³ã¯ãŸããCDSã®å°äœã®ããã®äººå¡é
眮ã®å€æŽææã«ã€ããŠãèšåããã2020幎12æããžã§ããµã³ã»ãã³ã¹å°è»ã¯ãCOVID-19ã¯ã¯ãã³ã®æäžã¯ååãªã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãããªãããåŸã«ã®ã¿è¡ããã¯ã¯ãã³ã®æ¥çš®ã矩åä»ãããã®ã§ã¯ãªããšåœããããã³ã¹å°è»ã¯ãã®çŽ1ãµæåŸã«è§£ä»»ãããããã®åŸãã¢ãŒãã»ãã¯ããã«ãæç£ãCDSã«ä»»åœãããCOVID-19ã¯ã¯ãã³ã®æ¥çš®ã矩åä»ããããåœããããããã¯ããã«ãæç£ã¯ãç¿æè§£ä»»ãããåã«ãããè¡ããªãã£ãã
ååããæå®³è³ åãæ±ããŠããã®ã¯ãæ·±å»ãã€æ°žç¶çãªå¿ççã»èäœçã»ç²Ÿç¥çå€å·ãéçšæ©äŒã®åªå€±ãäžååãªå»çæ¯æŽã«ãã身äœçå¥åº·ã®æªåãè
è¿«ãæŽè¡ãç¡ç æéã®åªå€±ãä»è
ãžã®ä¿¡é Œã®åªå€±ãèªä¿¡ã®åªå€±ãåå
¥ã®åªå€±ãå°æ¥ã®åå
¥ãåŸãæ©äŒã®åªå€±ãå¿çå€å·åŸã¹ãã¬ã¹é害ãªã©ã§ããã
åå1人åœãã100äžãã«ãšããç®æšé¡ã«ã€ããŠå°ããããã¯ãªã¹ãã³ã»ã³ã¯ããã£ãšé«ãæ°åã«ãªãå¯èœæ§ããã£ãããååãã¡ã¯å€§éãããæ£çŸ©ãéèŠããŠããããšçããã
ã被åã¯ïŒèªåãã¡ã®ä»²éã«ã²ã©ãããšããããèªåãã¡ã®ãªã¹ã¯ã®äœãããšã®ããã«ãäœå人ãã®è»éã倱ãå¿ èŠã¯ãªãã£ãã®ã§ãã
ã¯ãªã¹ãã³ã»ã³ã¯ãcfbãšãã¢ã³ãã³ã®ããã1000ã®ã«ã«ããcafã®ç§ã«ãã£ãŠã¢ã¯ã»ã¹ããããšè¿°ã¹ãã